152404-45-0

Basic information

• Product Name: 4-BROMOANISOLE-2,3,5,6-D4
• Synonyms: 4-BROMOANISOLE-2,3,5,6-D4;4-BroMoanisole--d4
• CAS NO: 152404-45-0
• Molecular Formula: C₇H₇BrO
• Molecular Weight: 191.06
• Mol File: 152404-45-0.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-BROMOANISOLE-2,3,5,6-D4(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMOANISOLE-2,3,5,6-D4(152404-45-0)
• EPA Substance Registry System: 4-BROMOANISOLE-2,3,5,6-D4(152404-45-0)

Safety Data

• Hazardous Substances Data: 152404-45-0(Hazardous Substances Data)

Usage

Description

4-BROMOANISOLE-2,3,5,6-D4 is an isotopically labeled research compound with the CAS number 152404-45-0. It is primarily utilized in scientific research and development for various applications due to its unique isotopic composition.

Uses

Used in Research and Development:
4-BROMOANISOLE-2,3,5,6-D4 is used as a research compound for [application reason] in the field of [application industry]. Its isotopic labeling allows for enhanced tracking and analysis in various experimental setups, contributing to a better understanding of the subject matter.
Please note that the specific application reason and application industry are not provided in the materials. If you have more information about the uses of 4-BROMOANISOLE-2,3,5,6-D4, please provide it, and I can tailor the response accordingly.

Upstream product

• 1076-43-3 benzene-d6 
• 4165-57-5 bromobenzene-d5 
• 50629-14-6 2,3,4,5,6-pentadeuterio-1-methoxybenzene 
• 4165-62-2 phenol-d5 
• 104-92-7 1-bromo-4-methoxy-benzene 
• 13127-88-3 phenol-d6 
• 126839-97-2 C₆⁽²⁾H₅BrO 
• 74-88-4 methyl iodide 
• 152404-44-9 [2′,3′,5′,6′-d₄]bromophenol 

Downstream Products

• 152404-46-1 4-methoxy-<2,3,5,6-2H4>benzoic acid 
• 152404-48-3 3,5-dibromo-4-hydroxy-<2,6-2H2>benzoic acid 
• 152404-47-2 [2′,3′,5′,6′-D4]-4′-hydroxybenzoic acid 

Relevant articles and documents

Iron-Catalyzed Highly Enantioselective Hydrogenation of Alkenes

Here, we reported for the first time an iron-catalyzed highly enantioselective hydrogenation of minimally functionalized 1,1-disubstituted alkenes to access chiral alkanes with full conversion and excellent ee. A novel chiral 8-oxazoline iminoquinoline ligand and its iron complex have been designed and synthesized. This protocol is operationally simple by using 1 atm of hydrogen gas and shows good functional group tolerance. A primary mechanism has been proposed by the deuterium-labeling experiments.

Entry to 1,2,3,4-Tetrasubstituted Arenes through Addressing the " Meta Constraint" in the Palladium/Norbornene Catalysis

Arenes with four different contiguous substituents, i.e. 1,2,3,4-tetrasubstituted arenes, are commonly found in bioactive compounds, but they are nontrivial to access via conventional methods. Through addressing the "meta constraint" in the palladium/norbornene (Pd/NBE) cooperative catalysis, which is the difficulty of tolerating a sizable meta substituent in aryl halide substrates, here a modular and regioselective approach is realized for preparing 1,2,3,4-tetrasubstituted arenes. One key is the use of a C2-amide-substituted NBE, and a combined experimental and computational study reveals its role in promoting the NBE insertion and the ortho C-H metalation steps. The scope is broad: A variety of electrophiles and nucleophiles could be introduced to the ortho and ipso positions, respectively, with 1,4-disubstituted aryl halides, leading to diverse unsymmetrical contiguous tetrasubstituted arenes. Application of this approach has been demonstrated in streamlined syntheses of several bioactive compounds.

Studies on the biosynthesis of the antibiotic reductiomycin in Streptomyces xanthochromogenus

The biosynthesis of the antibiotic reductiomycin (1) in Streptomyces xanthochromogenus was investigated by feeding experiments with radioactive and stable isotope-labeled precursors. NMR and mass spectroscopic analyses of the labeled 1 samples revealed th